Table 3.
Treatments | AsA (µg/mL) | FBS (%) | BSL (µL/mL) |
---|---|---|---|
TRT-Con | 0 | 0 | 0 |
TRT-1 | 0 | 10 | 0 |
TRT-2 | 0 | 10 | 10 |
TRT-3 | 0 | 0 | 10 |
TRT-4 | 40 | 10 | 0 |
TRT-5 | 40 | 10 | 10 |
TRT-6 | 40 | 0 | 10 |
Treatments | AsA (µg/mL) | FBS (%) | BSL (µL/mL) |
---|---|---|---|
TRT-Con | 0 | 0 | 0 |
TRT-1 | 0 | 10 | 0 |
TRT-2 | 0 | 10 | 10 |
TRT-3 | 0 | 0 | 10 |
TRT-4 | 40 | 10 | 0 |
TRT-5 | 40 | 10 | 10 |
TRT-6 | 40 | 0 | 10 |